Richard Shubin

1.2k total citations
15 papers, 675 citations indexed

About

Richard Shubin is a scholar working on Epidemiology, Animal Science and Zoology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard Shubin has authored 15 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Animal Science and Zoology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard Shubin's work include Animal Virus Infections Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Richard Shubin is often cited by papers focused on Animal Virus Infections Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Richard Shubin collaborates with scholars based in United States and Italy. Richard Shubin's co-authors include Stephen A. Stohlman, Mark A. Sussman, Ricki Robinson, John O. Fleming, Shigeru Kyuwa, Nancy Casteel, Amy E. Lovett‐Racke, Edward Fox, Sibyl Wray and Matthew Gormley and has published in prestigious journals such as Neurology, Journal of Virology and Virology.

In The Last Decade

Richard Shubin

15 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Shubin United States 12 179 167 131 125 121 15 675
Eduard Linetsky Israel 11 60 0.3× 72 0.4× 78 0.6× 265 2.1× 108 0.9× 24 734
Atsuo Nezu Japan 16 190 1.1× 21 0.1× 27 0.2× 154 1.2× 129 1.1× 48 1.0k
Anjali Varma United States 10 96 0.5× 16 0.1× 181 1.4× 52 0.4× 372 3.1× 15 954
Winnie Pao United States 9 53 0.3× 61 0.4× 292 2.2× 245 2.0× 148 1.2× 9 862
Brian Herron United Kingdom 15 56 0.3× 23 0.1× 56 0.4× 103 0.8× 125 1.0× 43 904
Roberto Poma Canada 16 50 0.3× 22 0.1× 34 0.3× 37 0.3× 22 0.2× 25 519
Ada Baisre United States 10 191 1.1× 112 0.7× 34 0.3× 41 0.3× 84 0.7× 30 671
Reghann G. LaFrance‐Corey United States 16 169 0.9× 24 0.1× 217 1.7× 172 1.4× 55 0.5× 22 871
L S Lange United Kingdom 11 66 0.4× 8 0.0× 49 0.4× 87 0.7× 157 1.3× 17 608
Tomoko Tanaka United States 12 46 0.3× 22 0.1× 71 0.5× 143 1.1× 55 0.5× 42 501

Countries citing papers authored by Richard Shubin

Since Specialization
Citations

This map shows the geographic impact of Richard Shubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Shubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Shubin more than expected).

Fields of papers citing papers by Richard Shubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Shubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Shubin. The network helps show where Richard Shubin may publish in the future.

Co-authorship network of co-authors of Richard Shubin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Shubin. A scholar is included among the top collaborators of Richard Shubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Shubin. Richard Shubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Fox, Edward, Amy E. Lovett‐Racke, Matthew Gormley, et al.. (2020). A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. Multiple Sclerosis Journal. 27(3). 420–429. 83 indexed citations
2.
Lovett‐Racke, Amy E., Matthew Gormley, Yue Liu, et al.. (2019). B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients. Journal of Neuroimmunology. 332. 187–197. 39 indexed citations
3.
4.
5.
Deer, Timothy R., Jason E. Pope, Ramsin Benyamin, et al.. (2016). Prospective, Multicenter, Randomized, Double-Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Novel Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin. Neuromodulation Technology at the Neural Interface. 19(1). 91–100. 93 indexed citations
6.
Brandes, David, et al.. (2007). Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular interferon beta‑1a therapy: a pilot study. Current Medical Research and Opinion. 23(7). 1667–1672. 17 indexed citations
7.
Shubin, Richard, et al.. (2002). Rapid Eye Movement Sleep Behavior Disorder in Children With Autism. Journal of Child Neurology. 17(3). 173–178. 105 indexed citations
8.
Shubin, Richard, et al.. (2000). Successful Treatment for Stroke in a Child Using Recombinant Tissue Plasminogen Activator. Journal of Child Neurology. 15(8). 558–558. 45 indexed citations
9.
Shubin, Richard, et al.. (2000). The use of citalopram in resistant cataplexy. Sleep Medicine. 1(4). 313–316. 15 indexed citations
10.
Yokomori, Kyoko, Miyuki Asanaka, Stephen A. Stohlman, et al.. (1995). Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. Journal of NeuroVirology. 1(5-6). 330–339. 23 indexed citations
11.
Waters, Cheryl, Hiroyuki Takahashi, Kirk C. Wilhelmsen, et al.. (1993). Phenotypic expression of X‐linked dystonia‐parkinsonism (lubag) in two women. Neurology. 43(8). 1555–1555. 36 indexed citations
12.
Shubin, Richard, Mark A. Sussman, John O. Fleming, & Stephen A. Stohlman. (1990). Relapsing encephalomyelitis following transfer of partial immunity to JHM virus. Microbial Pathogenesis. 8(5). 305–314. 8 indexed citations
13.
Fleming, John O., Richard Shubin, Mark A. Sussman, Nancy Casteel, & Stephen A. Stohlman. (1989). Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 168(1). 162–167. 104 indexed citations
14.
Sussman, Mark A., Richard Shubin, Shigeru Kyuwa, & Stephen A. Stohlman. (1989). T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. Journal of Virology. 63(7). 3051–3056. 90 indexed citations
15.
Stohlman, Stephen A., Mark A. Sussman, Glenn K. Matsushima, Richard Shubin, & Stephanie S. Erlich. (1988). Delayed-type hypersensitivity response in the central nervous system during JHM virus infection requires viral specificity for protection. Journal of Neuroimmunology. 19(3). 255–268. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Linetsky Breakdown of academic impact, for papers by Atsuo Nezu Breakdown of academic impact, for papers by Anjali Varma Breakdown of academic impact, for papers by Winnie Pao Breakdown of academic impact, for papers by Brian Herron Breakdown of academic impact, for papers by Roberto Poma Breakdown of academic impact, for papers by Ada Baisre Breakdown of academic impact, for papers by Reghann G. LaFrance‐Corey Breakdown of academic impact, for papers by L S Lange Breakdown of academic impact, for papers by Tomoko Tanaka
Rankless by CCL
2026